MXUMUFQZUKAXKE-UHFFFAOYSA-N
C19H22Cl2N4O5S2 — CID 11706300
Data last refreshed: (MolForge compound catalog, from PubChem)
About MXUMUFQZUKAXKE-UHFFFAOYSA-N
MXUMUFQZUKAXKE-UHFFFAOYSA-N (PubChem CID 11706300) has the molecular formula C19H22Cl2N4O5S2 and a molecular weight of 521.45 g/mol. Its IUPAC name is butyl 5-chloro-6-[4-[(5-chlorothiophen-2-yl)sulfonylcarbamoyl]piperazin-1-yl]pyridine-3-carboxylate.
Molecular Properties
| Compound Name | MXUMUFQZUKAXKE-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 11706300 |
| Molecular Formula | C19H22Cl2N4O5S2 |
| Molecular Weight | 521.45 g/mol |
| Exact Mass | 520.04 |
| IUPAC Name | butyl 5-chloro-6-[4-[(5-chlorothiophen-2-yl)sulfonylcarbamoyl]piperazin-1-yl]pyridine-3-carboxylate |
| SMILES | CCCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 |
| InChI | InChI=1S/C19H22Cl2N4O5S2/c1-2-3-10-30-18(26)13-11-14(20)17(22-12-13)24-6-8-25(9-7-24)19(27)23-32(28,29)16-5-4-15(21)31-16/h4-5,11-12H,2-3,6-10H2,1H3,(H,23,27) |
| InChIKey | MXUMUFQZUKAXKE-UHFFFAOYSA-N |
| XLogP | 3.63 |
| TPSA | 108.91 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 521.45 |
| LogP ≤ 5 | 3.63 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 11706300 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.